KC
HOLX

Kades & Cheifetz’s Hologic HOLX Stock Holding History

Kades & Cheifetz’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,772
Closed -$280K – 95
2024
Q2 		$280K Sell
3,772
-53
-1% -$3.97K 0.18% 78
2024
Q1 		$298K Sell
3,825
-166
-4% -$12.3K 0.19% 74
2023
Q4 		$285K Sell
3,991
-2,381
-37% -$166K 0.2% 71
2023
Q3 		$442K Hold
6,372
– – 0.35% 52
2023
Q2 		$516K Hold
6,372
– – 0.4% 51
2023
Q1 		$514K Buy
6,372
+218
+4% +$17.6K 0.41% 49
2022
Q4 		$460K Buy
+6,154
New +$438K 0.38% 51

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Kades & Cheifetz's HOLX Position: Q3 2024 in Review

Kades & Cheifetz sold out of Hologic (HOLX) in Q3 2024, closing a stake of 3,772 shares — an estimated $280K sold.

Kades & Cheifetz first reported a position in HOLX in Q4 2022 and held it in 7 quarters. The position peaked at $516K in Q2 2023. 726 funds tracked by Wall St. Rank hold HOLX as of Q3 2024.

  • Kades & Cheifetz reported no remaining Hologic position as of Q3 2024 after selling out during the quarter.
  • Kades & Cheifetz sold 3,772 Hologic shares in Q3 2024, an estimated $280K.
  • Kades & Cheifetz first reported a position in Hologic in Q4 2022 and held it in 7 quarters.
  • Kades & Cheifetz's Hologic position peaked at $516K in Q2 2023.
  • 726 funds tracked by Wall St. Rank held Hologic as of Q3 2024.

Based on Kades & Cheifetz's 13F filing for Q3 2024, filed 2 Oct 2024.